The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kontsevaia A.V.

Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny, Moskva

Kalinina A.M.

National Research Center for Preventive Medicine, Ministry of Health of Russia, Moscow

Balanova Iu.A.

Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny, Moskva

Luk'ianov M.M.

FGBU "GNITs profilakticheskoĭ meditsiny" Minzdrava RF, Moskva

Boytsov S.A.

National Research Centre for Preventive Medicine, Moscow, Russia

The association of cardiovascular diseases with influenza in different climatic and geographic regions and the efficiency of influenza vaccination as a way to prevent cardiovascular complications (an analytical review)

Authors:

Kontsevaia A.V., Kalinina A.M., Balanova Iu.A., Luk'ianov M.M., Boytsov S.A.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2012;15(6): 69‑75

Views: 1172

Downloaded: 45

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Kontsevaia AV, Kalinina AM, Balanova IuA, Luk'ianov MM, Boytsov SA. The association of cardiovascular diseases with influenza in different climatic and geographic regions and the efficiency of influenza vaccination as a way to prevent cardiovascular complications (an analytical review). Russian Journal of Preventive Medicine. 2012;15(6):69‑75. (In Russ.)

 
МСФ на ЯМ
Close metadata

The analytical review summarizes the results of studies of an association of the incidence of influenza and acute respiratory viral infections with cardiovascular outcomes; those of studies of the mechanisms of this association; data on the efficiency of vaccination as a way to prevent cardiovascular complications; the results of an analysis of the cost-effective expediency of vaccination in terms of the prevention of cardiovascular diseases. In accordance of the currently accumulated scientific and practical, mainly foreign, data, influenza vaccination has become a recommended secondary prevention strategy for cardiovascular diseases. However, the elaboration of effective vaccination programs and the economic rationale for their implementation call for national studies.

Keywords:

cardiovascular diseases
influenza
vaccination
prevention of cardiovascular events

Authors:

Kontsevaia A.V.

Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny, Moskva

Kalinina A.M.

National Research Center for Preventive Medicine, Ministry of Health of Russia, Moscow

Balanova Iu.A.

Gosudarstvennyĭ nauchno-issledovatel'skiĭ tsentr profilakticheskoĭ meditsiny, Moskva

Luk'ianov M.M.

FGBU "GNITs profilakticheskoĭ meditsiny" Minzdrava RF, Moskva

Boytsov S.A.

National Research Centre for Preventive Medicine, Moscow, Russia

List of references:

  1. Oganov R.G., Kontsevaya A.V., Kalinina A.M. Ekonomicheskii ushcherb ot serdechno-sosudistykh zabolevanii v Rossiiskoi Federatsii. Kardiovask ter i prof 2011; 4: 4-9.
  2. Revich B.A. Izmenenie zdorov'ya naseleniya Rossii v usloviyakh menyayushchegosya klimata. Probl prognoz 2010; 3: 140-150.
  3. Revich B.A. Volny zhara, kachestvo atmosfernogo vozdukha i smertnost' naseleniya evropeiskoi chasti Rossii letom 2010 g.: rezul'taty predvaritel'noi otsenki. Ekol chel 2011; 7: 3-9.
  4. Donaldson G.C., Keatinge W.R. Excess winter mortality: influenza or cold stress? BMJ 2002; 324: 89-90.
  5. Reichert T.A., Simonsen L., Sharma A., Pardo S.A., Fedson D.S., Miller M.A. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 2004; 160: 492-502.
  6. Madjid M., Casscells S.W. Of birds and men: cardiologists' role in influenza pandemics. Lancet 2004; 364: 1309.
  7. Spodick D.H., Flessas A.P., Johnson M.M. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984; 53: 481-482.
  8. Meier C.R., Jick S.S., Derby L.E., Vasilakis C., Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998; 351: 1467-1471.
  9. Smeeth L., Thomas S.L., Hall A.J., Hubbard R., Farrington P., Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351: 2611-2618.
  10. Warren-Gash C., Hayward A.C., Hemingway H., Denaxas S., Thomas S.L., Timmis A.D., Whitaker H., Smeeth L. Influenza Infection and Risk of Acute Myocardial Infarction in England and Wales: A CALIBER Self-Controlled Case Series Study. J Infect Dis 2012; 206: 1652-1659.
  11. Warren-Gash C., Bhaskaran K., Hayward A., Leung G.M., Lo S.V., Wong C.M., Ellis J., Pebody R., Smeeth L., Cowling B.J. Circulating influenza virus, climatic factors and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis 2011; 203: 1710-1718.
  12. Madjid M., Miller C.C., Zarubaev V.V., Marinich I.G., Kiselev O.I., Lobzin Y.V., Filippov A.E., Casscells S.W. 3rd. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 2007; 28: 1205-1210.
  13. Sprenger M.J., Mulder P.G., Beyer W.E., Van Strik R., Masurel N. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol 1993; 22: 334-340.
  14. Warren-Gash C., Smeeth L., Hayward A.C. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009; 9: 601-610.
  15. Dawood F.S., Iuliano A.D., Reed S., Meltzer M.I., Shay D.K., Cheng P.Y., Bandaranayake D., Breiman R.F., Brooks W.A., Buchy P., Feikin D.R., Fowler K.B., Gordon A., Hien N.T., Horby P., Huang Q.S., Katz M.A., Krishnan A., Lal R., Montgomery J.M., Molbak K., Pebody R., Presanis A.M., Razuri H., Steens A., Tinoco Y.O., Wallinga J., Yu H., Vong S., Bresee J., Widdowson M.A. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012; 12: 687-695.
  16. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322-1332.
  17. Saltykova T.S. Zabolevaemost' grippom i smertnost' ot boleznei serdechno-sosudistoi i dykhatel'noi sistem lits pozhilogo vozrasta. Ter arkhiv 2008; 11: 40-44.
  18. Fel'dblyum I.V., Naumov O.Yu., Devyatkov M.Yu., Polushkina A.V., Yakovlev I.B. Vaktsinatsiya protiv grippa kak instrument upravleniya riskom smertnosti ot boleznei sistemy krovoobrashcheniya. Epidemiol i vaktsinoprof 2011; 1: 64-67.
  19. Thompson W.W., Weintraub E., Dhankhar P., Cheng P.Y., Brammer L., Meltzer M.I., Bresee J.S., Shay D.K. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Virus 2009; 3: 37-49.
  20. Madjid M., Naghavi M., Litovsky S., Casscells S.W. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 2003; 108: 2730-2736.
  21. Greaves K., Oxford J.S., Price C.P., Clarke G.H., Crake T. The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection. Arch Intern Med 2003; 163: 165-168.
  22. Onitsuka H., Imamura T., Miyamoto N., Shibata Y., Kashiwagi T., Ayabe T., Kawagoe J., Matsuda J., Ishikawa T., Unoki T., Takenaga M., Fukunaga T., Nakagawa S., Koiwaya Y., Eto T. Clinical manifestations of influenza A myocarditis during the influenza epidemic of winter 1998-1999. J Cardiol 2001; 37: 315-323.
  23. Smeeth L., Cook C., Thomas S., Hall A.J., Hubbard R., Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006; 367: 1075-1079.
  24. Mattila K.J. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med 1989; 225: 293-296.
  25. Pesonen E., Andsberg E., Grubb A., Rautelin H., Meri S., Persson K., Puolakkainen M., Sarna S., Ohlin H. Elevated infection parameters and infection symptoms predict an acute coronary event. Ther Adv Cardiovasc Dis 2008; 2: 419-424.
  26. Guan X.R., Li X., Xin X.M., Jiang L.X., Cui L.Y., Wang L.F., Li H.Y. Influenza virus infection and risk of acute myocardial infarction. Inflammation 2008; 31: 266-272.
  27. Finelli L., Chaves S.S. Influenza and Acute Myocardial Infarction. J Infect Dis 2011; 203: 1701-1704.
  28. Naghavi M., Wyde P., Litovsky S., Madjid M., Akhtar A., Naguib S., Siadaty M.S., Sanati S., Casscells W. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 2003; 107: 762-768.
  29. Hingorani A.D., Cross J., Kharbanda R.K., Mullen M.J., Bhagat K., Taylor M., Donald A.E., Palacios M., Griffin G.E., Deanfield J.E., MacAllister R.J., Vallance P. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000; 102: 994-999.
  30. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., Willeit J., Schwartz D.A. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347: 185-192.
  31. Bridges C.B., Fukuda K., Cox N.J., Singleton J.A.; Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2001; 50: 1-44.
  32. Hunink M.G., Goldman L., Tosteson A.N., Mittleman M.A., Goldman P.A., Williams L.W., Tsevat J., Weinstein M.C. The recent decline in mortality from coronary heart disease, 1980-1990: the effect of secular trends in risk factors and treatment. JAMA 1997; 277: 535-542.
  33. Binder C.J., Horkko S., Dewan A., Chang M.K., Kieu E.P., Goodyear C.S., Shaw P.X., Palinski W., Witztum J.L., Silverman G.J. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003; 9: 736-743.
  34. Meyers D.G. Myocardial infarction, stroke, and sudden cardiac death may be prevented by influenza vaccination. Curr Atheroscler Rep 2003; 5: 146-149.
  35. Naghavi M., Barlas Z., Siadaty S., Naguib S., Madjid M., Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102: 3039-3045.
  36. Lavallée P., Perchaud V., Gautier-Bertrand M., Grabli D., Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002; 33: 513-518.
  37. Siscovick D.S., Raghunathan T.E., Lin D., Weinmann S., Arbogast P., Lemaitre R.N., Psaty B.M., Alexander R., Cobb L.A. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000; 152: 674-677.
  38. Grau A.J., Fischer B., Barth C., Ling P., Lichy C., Buggle F. Influenza vaccination is associated with a reduced risk of stroke. Stroke 2005; 36: 1501-1506.
  39. Pinol-Ripoll G., de la Puerta I., Santos S., Purroy F., Mostacero E. Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination. Cerebrovasc Dis 2008; 26: 339-347.
  40. Hung I.F., Leung A.Y., Chu D.W., Leung D., Cheung T., Chan C.K., Lam C.L., Liu S.H., Chu C.M., Ho P.L., Chan S., Lam T.H., Liang R., Yuen K.Y. Prevention of Acute Myocardial Infarction and Stroke among Elderly Persons by Dual Pneumococcal and Influenza Vaccination: A Prospective Cohort Study. Clin Infect Dis 2010; 51: 1007-1016.
  41. de Diego C., Vila-Corcoles A., Ochoa O., Rodriguez-Blanco T., Salsench E., Hospital I., Bejarano F., Del Puy Muniain M., Fortin M., Canals M.; EPIVAC Study Group. Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease. Eur Heart J 2009; 30: 209-216.
  42. Wang C.S., Wang S.T., Lai C.T., Lin L.J., Chou P. Impact of influenza vaccination on major cause-specific mortality. Vaccine 2007; 25: 1196-1203.
  43. Ghendon Y.Z., Kaira A.N., Elshina G.A. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect 2006; 134: 71-78.
  44. Jackson L.A., Yu O., Heckbert S.R., Psaty B.M., Malais D., Barlow W.E., Thompson W.W., Vaccine Safety Datalink Study Group. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002; 156: 634-640.
  45. Johnstone J., Loeb M., Teo K.K. Influenza Vaccination and Major Adverse Vascular Events in High-Risk Patients. Circulation 2012; 126: 278-286.
  46. Sacks H.S. Influenza vaccination reduced cardiovascular events in patients hospitalized with an acute coronary syndrome. Ann Intern Med 2011; 155: JC5-05.
  47. Gurfinkel E.P., de la Fuente R., Mendiz O., Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J 2004; 25: 25-31.
  48. Phrommintikul A., Kuanprasert S., Wongcharoen W., Kanjanavanit R., Chaiwarith R., Sukonthasarn A. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 2011; 32: 1730-1735.
  49. Ciszewski A., Bilinska Z.T., Brydak L.B., Kepka C., Kruk M., Romanowska M., Ksiezycka E., Przyluski J., Piotrowski W., Maczynska R., Ruzyllo W. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008; 29: 1350-1358.
  50. Nichol K.L. Influenza vaccination in the elderly: impact on hospitalization and mortality. Drugs Aging 2005; 22: 495-515.
  51. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons: a metaanalysis and review of the literature. Ann Intern Med 1995; 123: 518-527.
  52. Simonsen L., Reichert T.A., Viboud C., Blackwelder W.C., Taylor R.J., Miller M.D. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005; 165: 265-272.
  53. Loomba R.S., Aggarwal S., Shah P.H., Arora R.R. Influenza Vaccination and Cardiovascular Morbidity and Mortality. Analysis of 292 383 Patients. J Cardiovasc Pharmacol Ther 2012; 17: 277-283.
  54. Nichol K.L., Goodman M. Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years. Vaccine 2002; 15: Suppl 2: S21-S24.
  55. Drummond M., Chevat C., Lothgren M. Do we fully understand the economic value of vaccines? Vaccine 2007; 25: 5945-5957.
  56. Palache A.M. Influenza vaccines: a reappraisal of their use. Drugs 1997; 54: 841-856.
  57. Campbell D.S., Rumley M.H. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med 1997; 39: 408-414.
  58. Bridges C.B., Thompson W.W., Meltzer M.I., Reeve G.R., Talamonti W.J., Cox N.J., Lilac H.A., Hall H., Klimov A., Fukuda K. Effectiveness and costbenefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000; 284: 1655-1663.
  59. Demicheli V., Jefferson T., Rivetti D., Deeks J. Prevention and early treatment of influenza in healthy adults. Vaccine 2000; 18: 957-1030.
  60. Lugnér A.K., van Boven M., de Vries R., Postma M.J., Wallinga J. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. BMJ 2012; 345: e4445. doi: 10.1136/bmj.e4445.
  61. Otsenka riska i ushcherba ot klimaticheskikh izmenenii, vliyayushchikh na povyshenie urovnya zabolevaemosti i smertnosti v gruppakh naseleniya povyshennogo riska. Metodicheskie rekomendatsii 2.1.10.0057-12. M 2012; 48.
  62. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update. Circulation 2011; 124: 2458-2473.
  63. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012; 33: 1635-1701.
  64. Natsional'nye rekomendatsii po kardiovaskulyarnoi profilaktike. Kardiovask ter i prof 2011; 10: Prilozhenie 2.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.